Clover Health Investments, Corp. (CLOV) Research

Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.

Market snapshot

Symbol
CLOV
Price
$5.00
Day change
+4.17%
Market cap
$2.6B
P/E ratio
-45.85x
52-week range
1.58-5.18
Sector
Healthcare
Industry
Medical - Healthcare Plans
Next earnings
in 2 months
Analyst price target
$4.47

Recent news

  • Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating

    Clover Health Investments Corp. (NASDAQ:CLOV) shares are extending yesterday's 18.9% surge Thursday, after a court-ordered Medicare Star Rating upgrade jumped its PPO plan from 3.5 to 4.5 Stars.

Peer companies

  • BGM Group Ltd. (BGM)
  • Certara, Inc. (CERT)
  • Structure Therapeutics Inc. (GPCR)
  • Guardian Pharmacy Services, Inc. (GRDN)
  • LifeStance Health Group, Inc. (LFST)
  • National HealthCare Corporation (NHC)
  • PROCEPT BioRobotics Corporation (PRCT)
  • QuidelOrtho Corporation (QDEL)

Recent insider activity

  • Reynoso Jamie L. — S-Sale (2360 shares) on 2026-06-17
  • OLDAKOWSKI JOSEPH FRANK — S-Sale (12102 shares) on 2026-06-16
  • Soares Karen — S-Sale (4681 shares) on 2026-06-15
  • Reynoso Jamie L. — S-Sale (6350 shares) on 2026-06-15
  • Reynoso Jamie L. — S-Sale (7289 shares) on 2026-06-11

Open Clover Health Investments, Corp. (CLOV) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.